Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy
Chiarelli, F.; Mansour, M.; Verrotti, A.
Diabetes Nutrition and Metabolism 13(4): 192-199
2000
ISSN/ISBN: 0394-3402 PMID: 10961486 Document Number: 517117
Document emailed within 1 workday
Related Documents
González, M.; Paquién, C.; Asenjo, S.; Gleisner, A.; Kirsten, L.; Bustamante, M. 2001: Autoantibodies against advanced glycation products in patients with type 1 diabetes mellitus Revista Medica de Chile 129(2): 141-148Nakamura, N.; Yamazaki, K.; Satoh, A.; Urakaze, M.; Kobayashi, M.; Yamabe, H.; Osawa, H.; Shirato, K.-I.; Sugawara, T.; Nakamura, M.; Tamura, M.; Okumura, K. 2003: Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes In Vivo 17(2): 177-180
Semler, P.; Werner, U. 1976: Diabetes mellitus and microcirculation. Significance of diabetic angiopathy for the prognosis and course of diabetes mellitus, possibilities and bases of angiologic therapy Fortschritte der Medizin 94(7): 354-357
Soboleva, A.G.; Bruskin, S.A.; Nikolaev, A.A.; Sobolev, V.V.; Mezentsev, A.V. 2013: Role of receptor for advanced glycation end-products in pathgenesis of psoriasis Molekuliarnaia Biologiia 47(5): 743-753
Kalousová, M.; Zima, Táš. 2014: AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers Vnitrni Lekarstvi 60(9): 720-724
Mizuiri, S.; Miyata, S.; Sakai, K.; Kobayashi, M.; Miyagi, M.; Nakanishi, T.; Liu, B.F.; Kojima, H.; Hasegawa, A. 1999: Effect of intraperitoneal administration of heparin on advanced glycation end-products in CAPD Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(4): 361-365
Linden, T.; Forsbäck, G.; Deppisch, R.; Henle, T.; Wieslander, A. 1998: 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 18(3): 290-293
Brancaccio, D.; Gallieni, M.; Niwa, T.; Braidotti, P.; Coggi, G. 2000: Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis Journal of Nephrology 13(2): 129-136
Boulanger, E.; Wautier, J.-L.; Dequiedt, P.; Schmidt, A.-M. 2006: Glycation, glycoxidation and diabetes mellitus Nephrologie and Therapeutique 2(Suppl 1): S8-16
Dozio, E.; Bandera, F.; Vianello, E.; Brizzola, S.; Tacchini, L.; Corsi Romanelli, M.M. 2018: Upregulation of circulating levels of receptor for advanced glycation end products (sRAGE) in obese rats may protect against ectopic fat accumulation in the heart Journal of Biological Regulators and Homeostatic Agents 32(4 Suppl. 1): 32
Yoshida, S.; Yamada, K.; Hamaguchi, K.; Nishimura, M.; Hatakeyama, E.; Tsuchida, H.; Sakamoto, K.; Kashiwabara, H.; Yokoyama, T.; Ikeda, K.; Horiuchi, S. 1998: Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation Clinical Nephrology 49(5): 273-280
Ratnaike, S.; Blake, D.; Shevenan, P. 1987: Enzymic glycation may decrease activity of erythrocytic delta-aminolevulinate dehydratase in diabetes mellitus Clinical Chemistry 33(10): 1807-1810
Yamagishi, S.; Takeuchi, M. 2004: Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation Drugs under Experimental and Clinical Research 30(4): 169-175
Staniszewska, M.; Jarosz, J.; Jon, M.; Gamian, A. 2005: Advanced glycation end-products prepared in solution under high pressure contain epitopes distinct from those formed in the dry reaction at high temperature Archivum Immunologiae et Therapiae Experimentalis 53(1): 71-78
Spirichev, V.B.; Shatniuk, L.N.; Kodentsova, V.M.; Vrzhesinskaia, O.A.; Beketova NA et, A.L. 1997: Prophylactic food products in a diet of patients with diabetes++ mellitus, type Ii Voprosy Pitaniia 4: 26-31
Trivin, F. 1998: Role of Maillard products in the chronic complications of diabetes mellitus. Bioclinical applications Annales Pharmaceutiques Francaises 56(5): 193-196
Peerapatdit, T.; Likidlilid, A.; Patchanans, N.; Somkasetrin, A. 2006: Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus Journal of the Medical Association of Thailand 89(Suppl 5): S141-S146
Busch, W.; Götze, W.; Busch, G. 1973: Periodontopathies in diabetes mellitus with reference to the mouth hygiene index Deutsche Zahnarztliche Zeitschrift 28(2): 259-262
Gapparov, M.M. 1996: Sugar substitutes in specialized child nutrition products for the prevention and treatment of diabetes mellitus Voprosy Pitaniia 1996(5): 68-70
Keller, R.; Bohn, W. 1983: Tuberculosis in metabolic diseases with special reference to diabetes mellitus and hepatopathies Praxis und Klinik der Pneumologie 37 Suppl. 1: 442-446